One of the most baffling diseases is muscular dystrophy. Muscular dystrophy (MD) is a group of genetic disease that causes weakness and progressive degeneration of skeletal muscles. There are 9 major forms of MD – Duchenne, Becker, myotonic, limb-girdle, facioscapulohumeral, oculopharyngeal, Emery-Dreifuss, distal and congenital(Parker 2002). This essay will focus on the causes and pathological effects of Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) which are the most prevalent form of muscular dystrophy.
DMD and BMD are the most common childhood forms of muscular dystrophy. DMD was first described by the French physician Duchenne de Boulogne in 1868 (Hendriksen & Vles 2006). Beggs & Kunkel (1990) noted that DMD affects 1 in 3500 males while one-third of the cases are sporadic with no previous family history of DMD. DMD and BMD are X-linked recessive muscle-wasting disorders which normally occur in man. They are caused by a mutation in a gene located on the X-chromosome which codes for a protein called dystrophin (Cyrulnik & Hinton 2008). Campbell (1995) stated that the gene is extremely large and complex. Its locus extends over 2400 kb and approximately 14 kb is transcribed into an mRNA comprising 79 exons (Fig1).
Prices start at $12
Prices start at $11
Prices start at $14
Prices start at $12
Fig1. The dystrophin gene. A map of the 79 exons of dystrophin, spanning 2.4million bases and shows the 5 different promoters(C, M, P, S, G). Bars represent approximate relative positions of exons. (Ahn & Kunkel 1993). The Causes of DMD and BMD. Almost 70% of cases of DMD and more than 80% of cases of BMD are caused by gene deletion (Brown & Dickson 1994). Even though deletions can occur almost anywhere within the dystrophin gene, they are more likely to be found either around exons 45-55 (1200 kb from the 5′ end of the gene) or close to the first 20 exons (500 kb from the 5′ end) (Brown & Dickson 1994; Ahn & Kunkel 1993).
The site of deletion does not show whether it will cause BMD or DMD. Ahn & Kunkel(1993) suggested that BMD sometimes had a deletion of genes more than DMD. The determination of BMD and DMD is by analyzing the ways of deletions. Frameshift deletions will cause totally functional inactivity of protein and result in DMD while in-frame deletions will cause a partially inactivity of protein and result in BMD (Beggs & Kunkel 1990).
The role of dystrophin. Petrof, Shrager, Stedman, Kelly & Sweeney (1993) pointed that dystrophin is normally found on the cytoplasmic surface of skeletal muscle cell membranes. It mainly serves a mechanical role in muscles cells by linking the cortical actin cytoskeleton to the extracellular matrix(Winder 2006). The loss of linkage between the actin cytoskeleton and the extracellular matrix renders the muscle fibres vulnerable to mechanical damage during activity (Ahn & Kunkel 1993). Fig 2 shows the dystrophin protein in muscular dystrophy patients. Figure 2. Analysis of dystrophin by western blotting.
Normal-sized dystrophin is indicated; samples in lanes 2, 4, and 6 contain absent or abnormal dystrophin. So, lane 2 represents a patient with DMD; lane 4 represents BMD, and lane 6 represents severe BMD (low abundance of dystrophin). Patterns in lanes 1, 3, 5, and 7 are from normal controls. Comparison with levels of myosin (below) allows normalization for amounts of total muscle protein loaded. (Beggs & Kunkel 1990)
The Pathology of DMD and BMD. DMD and BMD have the same kind of pathological symptoms. The major difference between DMD and BMD is that the onset age for BMD is later and the progression is slower (Beggs & Kunkel 1990). The symptoms of DMD usually become obvious when a child begins walking. Some early signs include weakness and difficulties in standing up and climbing up (Moser 1984). Patients generally require a wheelchair at around 12 years old (Worton 1992). Parker (2002) concluded that death is due to respiratory failure and it usually occurs in their late teens or early 20s. In contrast, the average age of requiring a wheelchair for BMD is about 30 (Wada, Itoh, Furukawa, Tsukagoshi & Arahata 1990). Hendriksen& Vles (2006) acknowledged that males affected by Duchenne muscular dystrophy are at a higher risk of developing reading problems.
Muscular dystrophy is a genetic disease caused by the mutation of genes. The crucial result of this mutation is progressive, and ultimately lethal, muscular weakness. Patients always are deficient in protein dystrophin which is a major protein for protecting muscles. It plays a mechanical role by linking the cortical actin cytoskeleton to the extracellular matrix. The most/only common forms of muscular dystrophy are DMD and BMD. They have similar pathology but DMD is more severe where the patients usually die before the age of 30. Perhaps a further investigation into the role of dystrophin on different forms of muscular dystrophy might provide insight into generalised treatments for muscular dystrophy. (673 words)
- Ahn AH, Kunkel LM (1993) The structural and functional diversity of dystrophin. Nature genetics 3, 283 -291
- Beggs AH, Kunkel LM (1990) Improved diagnosis of Duchenne/Becker muscular dystrophy. The journal of clinical investigation 85, 613 -619
- Brown SC, Dickson G (1994) Duchenne muscular dystrophy. In ‘from Genetics to Gene Therapy.’ (Ed. DS Latchman.) pp. 45-70. (BIOS Scientific Publishers Ltd: London, UK)
- Campbell KP (1995) Three muscular dystrophies. Loss of cytoskeleton-extracellular matrix linkage. Cell 80, 675 -679
- Cyrulnik SE, Hinton VJ (2008) Duchenne muscular dystrophy. A cerebellar disorder. Neuroscience and biobehavioral reviews. Cyrulnik 32, 486 -496
- Hendriksen JGM, Vles JSH (2006) Are Males With Duchenne Muscular Dystrophy at Risk for Reading Disabilities. Pediatric Neurology 34, 296 -300
- Moser H (1984) Duchenne muscular dystrophy. Pathogenetic aspects and genetic prevention. Human genetics 66, 17 -40
- Parker JN, Parker PM (2002) ‘The 2002 Official Patient’s Sourcebook on Muscular Dystrophy’. (ICON Group International Inc)
- Petrof BJ, Shrager JB, Stedman HH, Kelly AM and Sweeney HL (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proceedings of the National Academy of Sciences of the United States of America 90, 3710 -3714
- Wada Y, Itoh Y, Furukawa T, Tsukagoshi H and Arahata K (1990) Quadriceps myopathy. A clinical variant form of Becker muscular dystrophy.Journal of neurology 237, 310 -312
- Winder SJ (2006) ‘Molecular Mechanisms of Muscular Dystrophies’. (Landes Bioscience)
- Worton RG (1992) Duchenne muscular dystrophy. Gene and gene product; mechanism of mutation in the gene. Journal of inherited metabolic disease 15, 539 -550
- View Graded Grading Form – BIO1011 FINAL ESSAY FEEDBACK
- Your essay has been marked as a percentage out of 100. To convert this to a mark out of 10, divide the percentage by 10. e.g. A percentage of 75% converts to a mark of 7.5/10.